RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
Backround: RPL15 has been found to participate in human tumorigenesis. However, its function and regulatory mechanism in hepatocellular carcinoma (HCC) development are still unclear. Current study investigated the effects of RPL15 in HCC. Methods: The expression of RPL15 in clinical tissues and cell...
Main Authors: | Liu, Z. (Author), Shi, R. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
<it>TP</it>53 and <it>MDM2 </it>gene polymorphisms and risk of hepatocellular carcinoma among Italian patients
by: Buonaguro Franco M, et al.
Published: (2011-08-01) -
MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
by: Samy A. Azer
Published: (2018-03-01) -
Evolution of the p53-MDM2 pathway
by: Emma Åberg, et al.
Published: (2017-08-01) -
RPL32 Promotes Lung Cancer Progression by Facilitating p53 Degradation
by: Jiansheng Xie, et al.
Published: (2020-09-01) -
Regulation of the tumor suppressor p53 by Mdm2 and Mdm4
by: Maetens, Marion
Published: (2007)